Hedge Funds Have Never Been More Bullish On Heron Therapeutics Inc (HRTX)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors......(read more)
Posts Tagged ‘NASDAQ:HRTX’
Here’s What Hedge Funds Think About Heron Therapeutics Inc (HRTX)
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil......(read more)
Hedge Funds Are Buying Heron Therapeutics Inc (HRTX)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors......(read more)
Hedge Fund and Insider Trading News: Bridgewater Associates, Winton Capital, Heron Therapeutics Inc (HRTX), Accuray Incorporated (ARAY), and More
Hedge Funds Bridgewater, Winton Register to Launch Products in China (Reuters) SHANGHAI (Reuters) – Renowned global hedge fund managers Bridgewater......(read more)
Hedge Fund and Insider Trading News: Folger Hill Asset Management, Starboard Value LP, Unum Therapeutics Inc (UMRX), Spectrum Pharmaceuticals, Inc. (SPPI), Trinity Industries Inc (TRN), and More
Struggling Hedge Fund Folger Hill is Merging with Another Fund (Business Insider) Hedge fund Folger Hill Asset Management is merging with Schonfeld Strategic......(read more)
Hedge Fund and Insider Trading News: D.E. Shaw, Appaloosa Management, Bill Ackman, Arcus Biosciences Inc (RCUS), SCYNEXIS Inc (SCYX), RealNetworks Inc (RNWK), and More
Hedge Funds to Watch for Facebook Fallout: D.E. Shaw, Appaloosa (Bloomberg) Several prominent hedge funds could be among investors feeling the pain from......(read more)
Market Movers Today: Facebook, Inc. (FB), Geron Corporation (GERN), Heron Therapeutics Inc (HRTX), Micro Focus International PLC – ADR (MFGP), and More
Facebook, Inc. (NASDAQ:FB) (Los Angeles Times) Facebook Inc.’s stock tumbled Monday after the social media company accused a data analytics firm......(read more)
Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN
In new guidelines, Heron Therapeutics Inc (NASDAQ:HRTX) has announced that Sustol will be included as an extended-release injection. A recommendation......(read more)
Legendary Railroad Executive Offloads Huge Amount of Shares After Announcing Decision to Retire from Canadian Pacific Railway, Plus Other Insider Trading
Assuming corporate insiders know a lot more about their company’s prospects and recent developments than any of us, which they do, investors would be......(read more)
Is Heron Therapeutics Inc (HRTX) a Good Stock To Buy?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of......(read more)
Here’s Why TASER International, Heron Therapeutics and Three Other Stocks Are Trading Lower on Monday
The markets have opened the fourth quarter on a negative note. While there are uncertainties on account of upcoming presidential election and deteriorating......(read more)
What’s In The Latest Heron Therapeutics Inc (HRTX) Data?
Heron Therapeutics Inc (NASDAQ:HRTX) just announced topline from its two lead pain management phase II trials. The trials were set up to investigate the......(read more)
Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others
Kevin Kotler‘s healthcare-focused fund Broadfin Capital held a 13F portfolio valued at about $1.04 billion at the end of the first quarter, according......(read more)
Why Are Investors Piling Into These 5 Surging Stocks?
It’s a day of diverging indexes as the S&P 500 is up by 0.37% while the NASDAQ is down by 0.20%. The diverging results are due to various earnings......(read more)
Heron Therapeutics, Inc. (HRTX): Tang Capital Partners Raises Stake to 17%
According to a newly-amended 13D filing with the US SEC, Kevin C. Tang‘s Tang Capital Management owns 6.53 million shares of Heron Therapeutics......(read more)
Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1
Though 2016 hasn’t been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused......(read more)
Venrock’s VHCP Management’s Top Picks For 2016
At Insider Monkey, we look at the weighted average returns of the long positions a fund indicates in its 13F filings, in companies with a market cap greater......(read more)
Hedge Funds Are Hoarding Shares Of Heron Therapeutics Inc (HRTX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.......(read more)
VHCP Management Produced Impressive Returns From Its Pharma Stock Picks In The Turbulent Third Quarter
With losses in the high single-digits and volatility hitting the roof, the third quarter of 2015 turned out to be a troublesome period for the equity......(read more)
Three Biotech Stocks Are Down Today but Hedge Funds Say They Are Not Out
Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Intrexon Corp (NYSE:XON), and Heron Therapeutics Inc (NASDAQ:HRTX) are down significantly today amid......(read more)
These Biotech Stocks Move in Opposing Directions Today and Hedge Funds Say You Should Bet on One of Them
Shares of Heron Therapeutics Inc (NASDAQ:HRTX) are up by more than 20% in early trading, following positive Phase 2 reports on HTX-011, an anesthetic......(read more)
Christopher Medlock Doesn’t Think Heron Therapeutics Inc (HRTX)’s Gains This Year Will Stop At A Mere 220%
Christopher Medlock James‘ Partner Fund Management recently initiated a position in Heron Therapeutics Inc (NASDAQ:HRTX), together with its affiliated......(read more)
Kingdon Capital Raises Stakes in XOMA Corp (XOMA) and Heron Therapeutics Inc (HRTX)
In two new filings with the U.S. Securities and Exchange Commission today, Kingdon Capital, led by Mark Kingdon, disclosed that it upped its passive stakes......(read more)
Heron Therapeutics Inc Shares Take Wing on Big Insider Buy
On a down day for the Nasdaq, shares of biotech Heron Therapeutics Inc (NASDAQ:HRTX) were faring worse than most in Tuesday trading — until suddenly......(read more)
Heron Therapeutics Inc (HRTX), La Jolla Pharmaceutical Company (LJPC), Salix Pharmaceuticals, Ltd. (SLXP) Are Tang Capital’s Largest Bets in Q4
Kevin Tang‘s Tang Capital Partners is one of the funds that have already revealed their equity portfolios as of the end of last year. The healthcare......(read more)
Andrew R. Midler’s Savitr Capital Loves Small-Caps
Andrew R. Midler’s Savitr Capital recently declared, with the SEC, its long equity positions as of June 30 2014. The fund disclosed a relatively small......(read more)
